We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement
Analytical Cannabis Logo
×
Home > Policy

Cannabis Policy

Medical Cannabis Significantly Improves Quality of Life, Finds Europe’s Largest Patient Study

Project Twenty21, Europe’s largest ever medical cannabis patient study, has released its first preliminary results – the first real-world data to be published on medical cannabis patients in the United Kingdom.

Read More

Harsh European Cannabis Laws Don’t Deter Frequent Consumers, Study Finds

The researchers found that while restrictive intervention does appear to decrease the share of adolescents initiating cannabis use, there was no evidence of policy changes impacting the share of frequent cannabis users.

Read More

Denmark Extends its Medical Cannabis Trial

The trial was due to expire this December, but the Danish government has announced that parts of the scheme will be extended for another four years.

Read More

Cannabis “Poisonings” Are on the up After Legalization, Say US Poison Centers

The research, which used data from US poison centers, found such facilities are increasingly receiving calls about adverse events associated with cannabis products.

Read More

Cannabis Legalization Increases Heroin Prices, Study Finds

Changes in state recreational cannabis laws can have a significant knock-on effect on the illegal market for other drugs, claims a new study.

Read More

Florida Opens Its Sixth Cannabis Testing Lab

Method Testing Labs has received a Certified Marijuana Testing Laboratory (CMTL) status from the Florida Department of Health, thereby becoming the sixth such lab company in the state to be approved to test cannabis.

Read More

DEA Finally Close to Expanding the Number of Suppliers For Cannabis Research

The announcement is one of the first major cannabis-related actions to come out of the Biden administration.

Read More

Alabama Legalizes Medical Cannabis

The new program will allow patients who live with one of 16 qualifying medical conditions, including cancer, a terminal illness, and depression, to buy medical cannabis with the recommendation of a doctor.

Read More

Federal Agency Sets a New Standard THC Dose For Cannabis Research

Effective from Friday May 7, 2021, US researchers are now required to measure and report results using the unit in all studies involving THC and human subjects.

Read More

 
Advertisement